Videos

The Richard Nixon Presidential Library and Museum hosted an event marking the 50th anniversary of the signing of the National Cancer Act. This panel featured doctors from some the top cancer…

The Richard Nixon Presidential Library and Museum hosted an event marking the 50th anniversary of the signing of the National Cancer Act. This panel included nobel laureates who reflected on…

The Richard Nixon Presidential Library and Museum hosted an event marking the 50th anniversary of the signing of the National Cancer Act of 1971. This panel featured experts in a variety of …

Panelists offered advice on biomedical innovation, health care, and drug pricing to the Trump administration at a conference called “Partnering for Cures.” Speakers included health policy ad…

Officials from the National Institutes of Health, the Food and Drug Administration, and the University of Michigan Medical School testified on the state of biomedical innovation and the sear…

Panelists spoke about the state of cancer research and public policy. They focused on facilitating the rapid transfer of promising cancer drug and treatment discoveries from the laboratory t…

Witnesses testified about safety inspections by U.S. government officials of foreign drug imports. They focused on a lack of resources for the Food and Drug Administration (FDA) to inspect o…

Panelists talked about medical and health research. Topics included the national agenda issues; strategies for winning influence for science; and the complicated issues that influence public…

Dr. Andrew Von Eschenbach talked about the Food and Drug Administration oversight of drugs, the drug approval and inspection process, and whether current funding levels are negatively impact…

Commissioner Andrew von Eschenbach talked about the challenges facing the Food and Drug Administration in a rapidly changing world. He specifically addressed advances in science and technolo…

Members of the Food and Drug Administration’s Science Board testified about the report, “The FDA Commission at Risk,” that they helped write. Topics included the FDA’s inability to fulfill i…

Witnesses testified about increasing numbers of Alzheimer’s disease cases, public education efforts by several federal agencies, other research and health care programs, as well as levels of…

Committee investigators, food safety experts and FDA officials testified at a hearing titled: “Diminished Capacity: Can the FDA Assure the Safety and Security of the Nation’s Food Supply? Pa…

A hearing was held on the role of the Food and Drug Administration in evaluating the safety of Avandia, a drug used in the treatment of Type 2 diabetes. FDA officials testified about post-ma…

Andrew Von Eschenbach was interviewed food and drug safety, the recent pet food contamination, and the approval process for drugs. After he left, the reporters discussed his responses with t…

The acting Commissioner addressed an FDA Science Forum celebrating the agency’s 100th anniversary. His topic was, “Creating the FDA for the 21st Century.” He talked about the history of the…

Commissioner Von Eschenbach and former Food and Drug Commission commissioners testified about the safety of the food supply, recent reports of contamination similar to incidents of pet food …

Food and Drug Administration Commissioner Andrew C. von Eschenbach talked about efforts to balance drug safety, risk, benefit, and access in the prescription drug approval process. He also r…

Secretary Leavitt and other department officials spoke to reporters and answered questions about the proposed fiscal year 2008 budget for the Department of Health and Human Services.

Committee members heard testimony from Andrew von Eschenbach on his nomination to be commissioner of the Food and Drug Administration. They also heard testimony from Paul DeCamp on his nomin…